Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05164367 · ClinicalTrials.gov registry record · Early Phase 1
Pharmacokinetics of Atropine Oral Gel
A Early Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT05164367 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 10 participants.
The verdict
NCT05164367, a Early Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
To evaluate the single-dose pharmacokinetics of atropine gel formulation after topical administration in the oral cavity of healthy adults.
Interventions
- DRUG Atropine sulfate gel (0.01%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2024-12-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05164367
The ClinicalTrials.gov registry entry for NCT05164367 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atropine sulfate gel (0.01%) is the first listed.
NCT05164367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05164367 about?
NCT05164367 is a clinical study titled "Pharmacokinetics of Atropine Oral Gel". To evaluate the single-dose pharmacokinetics of atropine gel formulation after topical administration in the oral cavity of healthy adults.
What is the current status of trial NCT05164367?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2022-10-01. Estimated completion is 2024-12-10.
What interventions are being tested in trial NCT05164367?
The interventions under investigation include: Atropine sulfate gel (0.01%) (DRUG).
Who is sponsoring clinical trial NCT05164367?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.